The role of deferred cytoreductive nephrectomy in the era of immune checkpoint inhibitor

被引：0
|
作者：
Yaegashi, Hiroshi [1 ]
机构：
[1] Kanazawa Univ, Dept Integrat Canc Therapy & Urol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY13-3
引用
收藏
页码：S1362 / S1362
页数：1
相关论文
共 50 条
  • [21] The role of cytoreductive nephrectomy in perspectives of tumor immune microenvironment
    Park, J. S.
    Lee, M. E.
    Jang, W. S.
    Kim, J.
    Park, S. M.
    Ham, W. S.
    EUROPEAN UROLOGY, 2023, 83
  • [22] The role of cytoreductive nephrectomy in the immuno-oncological therapy era
    Magee, Diana E. E.
    Helstrom, Emma
    Kutikov, Alexander
    CURRENT OPINION IN UROLOGY, 2023, 33 (02) : 136 - 141
  • [23] Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors
    Shapiro, Daniel D.
    Abel, E. Jason
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 513 - 520
  • [24] Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC
    Das, Arighno
    Shapiro, Daniel D. D.
    Craig, Juliana K. K.
    Abel, E. Jason
    NATURE REVIEWS UROLOGY, 2023, 20 (11) : 654 - 668
  • [25] Toxicity in the era of immune checkpoint inhibitor therapy
    Keam, Synat
    Turner, Naimah
    Kugeratski, Fernanda G.
    Rico, Rene
    Colunga-Minutti, Jocelynn
    Poojary, Rayansh
    Alekseev, Sayan
    Patel, Anisha B.
    Li, Yuanteng Jeff
    Sheshadri, Ajay
    Loghin, Monica E.
    Woodman, Karin
    Aaroe, Ashley E.
    Hamidi, Sarah
    Iyer, Priyanka Chandrasekhar
    Palaskas, Nicolas L.
    Wang, Yinghong
    Nurieva, Roza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [26] Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC
    Arighno Das
    Daniel D. Shapiro
    Juliana K. Craig
    E. Jason Abel
    Nature Reviews Urology, 2023, 20 : 654 - 668
  • [27] The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 2319 patients
    Makrakis, Dimitrios
    Msaouel, Pavlos
    Karam, Jose A.
    Esagian, Stepan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 425 - 425
  • [28] Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered
    Stewart, Grant D.
    Aitchison, Michael
    Bex, Axel
    Larkin, James
    Lawless, Claire
    Mejean, Arnaud
    Nathan, Paul
    Oades, Grenville
    Patard, Jean-Jacques
    Paul, James
    Ravaud, Alain
    Escudier, Bernard
    EUROPEAN UROLOGY, 2017, 71 (06) : 845 - 847
  • [29] Cytoreductive Nephrectomy in the Targeted Treatment Era
    Yaycioglu, Ozgur
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (03): : 214 - 218
  • [30] Is cytoreductive nephrectomy relevant in the immunotherapy era?
    Singla, Nirmish
    Ghandour, Rashed A.
    Margulis, Vitaly
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 526 - 530
12345